发明名称 EFFECTIVE GENERATION OF TUMOR-TARGETED T CELLS DERIVED FROM PLURIPOTENT STEM CELLS
摘要 The present invention relates to the field of adoptive immunotherapy. The invention provides methods for generating phenotypically defined, functional, and/or expandable T cells from pluripotent stem cells engineered through safe genetic modifications. The engineered cells may provide one or more of: 1) targeting a specific predetermined antigen expressed on the cell surface of a target cell in an HLA independent manner, 2) enhanced survival and functional potential 3) “off-the-shelf” T cells for administration to multiple recipients, eventually across immunogenic barriers, and/or 4) cytotoxic potential and anti-tumor activity.
申请公布号 US2016009813(A1) 申请公布日期 2016.01.14
申请号 US201514873836 申请日期 2015.10.02
申请人 MEMORIAL SLOAN-KETTERING CANCER CENTER 发明人 Themeli Maria;Sadelain Michel;Kloss Christopher C.
分类号 C07K16/30;C07K14/47;C07K14/705;C12N5/0783;A61K35/17;C07K14/725 主分类号 C07K16/30
代理机构 代理人
主权项 1. A T cell that is generated from a pluripotent stem cell that expresses a chimeric antigen receptor (CAR).
地址 New York NY US